Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.93
-0.2100-1.89%
Post-market: 10.930.00000.00%19:30 EDT
Volume:199.42K
Turnover:2.21M
Market Cap:534.32M
PE:-3.41
High:11.60
Open:11.26
Low:10.76
Close:11.14
52wk High:14.53
52wk Low:2.22
Shares:48.89M
Float Shares:19.90M
Volume Ratio:0.63
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.54
PE(LYR):-3.19

Loading ...

Company Profile

Company Name:
Artiva Biotherapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
115
Office Location:
5505 Morehouse Drive,Suite 100,San Diego,California,United States
Zip Code:
92121
Fax:
- -
Introduction:
Artiva Biotherapeutics, Inc. was incorporated in the state of Delaware on February 14, 2019. The company is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients with devastating autoimmune diseases and cancer.

Directors

Name
Position
Fred Aslan
Director,Chief Executive Officer,Principal Accounting Officer and Principal Financial Officer
Alison Moore
Independent Director
Brian Daniels
Chairperson of the Board and Independent Director
Daniel Baker
Independent Director
Elaine Sorg
Independent Director
Elizabeth Hougen
Independent Director
Laura Stoppel
Independent Director

Shareholders

Name
Position
Fred Aslan
Director,Chief Executive Officer,Principal Accounting Officer and Principal Financial Officer
Jennifer Bush
Chief Operating Officer, Chief Legal Officer and Compliance Officer
Christopher P. Horan
Chief Technical Operations Officer
Diego Miralles
President and Head of Research and Development
Subhashis Banerjee
Chief Medical Officer